Comparative growth behaviour and characterization of stem cells from human Wharton's jelly.

@article{Fong2007ComparativeGB,
  title={Comparative growth behaviour and characterization of stem cells from human Wharton's jelly.},
  author={Chui-Yee Fong and M Richards and N Manasi and Arjit Biswas and Ariff Bongso},
  journal={Reproductive biomedicine online},
  year={2007},
  volume={15 6},
  pages={
          708-18
        }
}
Human embryonic stem cells (hESC) face ethical sensitivities and the problem of teratoma formation. Although Wharton's jelly stem cells (WJSC), also of embryonic origin, may not face such ethical concerns, it is not definitely known whether under hESC culture conditions they would be as pluripotent as hESC. WJSC grown on plastic showed two types of morphology (epithelioid and short fibroblastic) in primary culture depending on the culture medium used, and only fibroblastic morphology when… Expand
Extra-embryonic human Wharton's jelly stem cells do not induce tumorigenesis, unlike human embryonic stem cells.
TLDR
Human WJSC, being hypoimmunogenic and non-tumorigenic, have the potential for safe cell-based therapies and are isolated and characterized from the extra-embryonic human umbilical cord Wharton's jelly. Expand
The Treasury of Wharton's Jelly.
TLDR
The VSELs-like cells express all of the pluripotency-associated markers the authors investigated and are able to differentiate into meso- endo- and ectodermal precursor cells. Expand
Evaluation of the Capability of the Wharton's Jelly Mesenchymal Stem Cell Aggregates to Express the Markers of Three Germ Cell Lineages.
TLDR
These aggregates mainly kept their mesenchymal state and showed a poor differentiation potential toward ectoderm and endoderm identity. Expand
Human Wharton’s Jelly Stem Cells Have Unique Transcriptome Profiles Compared to Human Embryonic Stem Cells and Other Mesenchymal Stem Cells
TLDR
The ability to modulate immune responses makes hWJSCs an important compatible stem cell source for transplantation therapy in allogeneic settings without immunorejection and provides a foundation for future functional studies where the exact mechanisms of these unique properties of hW JSCs can be confirmed. Expand
Human Wharton's Jelly Stem Cells, its Conditioned Medium and Cell-Free Lysate Inhibit the Growth of Human Lymphoma Cells
TLDR
It is hypothesized that the growth of lymphoma cells is inhibited by the molecules secreted by hWJSCs that use oxidative stress pathways to induce cell death followed by engulfment of the apoptotic remains of the lymphomas cells by the hW JSCs. Expand
An in vitro model for hepatocyte-like cell differentiation from Wharton’s jelly derived-mesenchymal stem cells by cell-base aggregates
TLDR
A protocol for UCMSC differentiation into hepatocytes was established and these cells were morphologically and functionally similar to hepatocytes, suggesting hepatocyte differentiation may be facilitated by the UCMSCs aggregate formation before administration of the differentiation protocols. Expand
Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells.
TLDR
It is proposed that human WJSC may be frozen at the same time as UCB in cord blood banks for regenerative medicine purposes. Expand
Perinatal sources of mesenchymal stem cells: Wharton’s jelly, amnion and chorion
TLDR
This review highlights the characteristics and therapeutic potential of three human mesenchymal stem cell types obtained from perinatal sources: Wharton’s jelly, the amnion, and the chorion. Expand
Propagation and differentiation of human Wharton's jelly stem cells on three-dimensional nanofibrous scaffolds.
TLDR
This chapter provides a step-by-step protocol for the preparation of such tissue constructs involving hWJSCs and nanofibrous scaffolds that will facilitate clinical translation and improved functional outcome for arthritis, bone, and cartilage diseases. Expand
Human Wharton’s Jelly—Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials
TLDR
Umbilical cord, especially Wharton’s jelly, is a promising source of mesenchymal stem cells, which makes them a good alternative for allogeneic and xenogeneic transplantations in cellular therapies. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 29 REFERENCES
Mesenchymal Stem Cells in the Wharton's Jelly of the Human Umbilical Cord
TLDR
It is shown that mesenchymal cells isolated from the umbilical cord have multilineage potential and that, under suitable culture conditions, are able to differentiate into cells of the adipogenic and osteogenic lineages. Expand
Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells.
TLDR
MSCs could be isolated from human umbilical cord Wharton's Jelly and were capable of differentiating into nerve-like cells using Salvia miltiorrhiza or beta-mercaptoethanol and expressed neuron-related genes and neuronal cell markers. Expand
Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells
TLDR
It is shown that human fetal and adult fibroblast feeders support prolonged undifferentiated HES cell growth of existing cell lines and are superior to cell-free matrices supplemented with human or MEF feeder–conditioned medium. Expand
Matrix Cells from Wharton's Jelly Form Neurons and Glia
TLDR
Cells from the matrix of umbilical cord have properties of stem cells and may, thus, be a rich source of primitive cells, and their capacity to differentiate into a neural phenotype in vitro is shown. Expand
Human Umbilical Cord Perivascular (HUCPV) Cells: A Source of Mesenchymal Progenitors
TLDR
It is concluded that, due to their rapid doubling time, high frequencies ofCFU‐F and CFU‐O, and high MHC−/− phenotype, HUCPV cells represent a significant source of cells for allogeneic mesenchymal cell‐based therapies. Expand
A New Human Somatic Stem Cell from Placental Cord Blood with Intrinsic Pluripotent Differentiation Potential
TLDR
A new, intrinsically pluripotent, CD45-negative population from human cord blood, termed unrestricted somatic stem cells (USSCs) is described, which grows adherently and can be expanded to 1015 cells without losing pluripotency. Expand
Production of stem cells with embryonic characteristics from human umbilical cord blood
TLDR
The world's first reproducible production of cells expressing embryonic stem cell markers, – cord‐blood‐derived embryonic‐like stem cells (CBEs), which are a viable human alternative from embryonic stem cells for stem cell research, without ethical constraint and with potential for clinical applications are reported. Expand
Human Umbilical Cord Matrix Stem Cells: Preliminary Characterization and Effect of Transplantation in a Rodent Model of Parkinson's Disease
TLDR
The umbilical cord matrix appears to be a rich, noncontroversial, and inexhaustible source of primitive mesenchymal stem cells. Expand
Introducing a New Stem Cells Series
  • M. Rao
  • Biology, Medicine
  • Stem cells
  • 2007
TLDR
The large number of investigator-initiated studies, the necessity for propagating MSC in culture, and the extension of their use in allogenic situations has prompted the Food and Drug Administration to regulate MSC trials, much as they would any other investigational new drugs. Expand
Biology of Stem Cells in Human Umbilical Cord Stroma: In Situ and In Vitro Surveys
TLDR
Conclusively, HUCSCs retain their original phenotype in culture without spontaneous differentiation, have a limited lifespan, and bear multipotent stem cell characteristics, and deserve further study to be potentially used in cell‐based therapies. Expand
...
1
2
3
...